KABRA DRUGS LTD. - Board Meeting Outcome for Outcome Of The Board Meeting And Disclosure Under Regulation 30 Of SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e 30th May 2024, inter-alia, considered and approved the following: 1. Audited financial results for the quarter and the year ended 31st March, 2024 along with Independent Auditors Report 2. The Board discussed the compliance of the Statement of Deviation or Variation as per the Regulation 32 of SEBI (LODR) Regulations, 2015 and is of the view that the same is not applicable to company as the company has not issued any share by way of Public Issue, Right Issue, Preferential Issue etc. The undertaking of non-applicability of Regulation 32 of SEBI (LODR) Regulations, 2015 is enclosed herewith. 3. Appointment of Secretarial Auditor: Appointed as Secretarial Auditor of the Company to conduct Secretarial audit for the Financial Year 2023-24.